# Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab

> **NCT05889442** · NA · COMPLETED · sponsor: **Danish Headache Center** · enrollment: 16 (actual)

## Conditions studied

- Migraine Without Aura

## Interventions

- **DRUG:** Levcromakalim
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05889442
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-09
- **Primary completion:** 2023-06-12
- **Final completion:** 2023-06-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889442, "Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05889442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*